Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Em Crescimento
A empresa está em fase de crescimento, com a receita anual mais recente totalizando US$ 64.83M.
Sobreavaliada
O PE mais recente da empresa é -0.03, em uma faixa percentil alta de 3 anos.
Compra Institucional
As participações institucionais mais recentes são de 298.27K ações, um aumento de 25.57% em relação ao trimestre anterior.
Mantido por The Vanguard
O Super Investidor The Vanguard possui 2.03K ações desta empresa.
Baixa Atividade de Mercado
A empresa tem menor interesse dos investidores, com uma taxa de giro de 20 dias de -0.97.